Market Research Reports, Inc.

Global Injectable Drug Delivery Partnering 2010-2015 Market Report; Launched via MarketResearchReports.com

Market Research Reports, Inc. has announced the addition of “Global Injectable Drug Delivery Partnering 2010-2015” research report to their website http://www.MarketResearchReports.com

 

Lewes, DE -- (SBWIRE) -- 08/18/2015 -- Provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
Injectable Drug Delivery Partnering 2010-2015 report provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the world's leading healthcare companies.

Trends in injectable drug delivery partnering deals
Top injectable drug delivery deals by value
Deals listed by company A-Z, deal type, stage of development, therapy type

Injectable Drug Delivery Partnering 2010-2015 provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter injectable drug delivery partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors drug delivery technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This report contains over 150 links to online copies of actual injectable drug delivery deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of injectable drug delivery dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in injectable drug delivery dealmaking since 2010

Chapter 3 is the most popular chapter that includes details of average headline, upfront, milestone and royalty terms.

Chapter 4 provides a review of the leading injectable drug delivery deals since 2010. Deals are listed by headline value, most active of all biopharma companies and signed by big pharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides a comprehensive directory of injectable drug delivery partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and therapy type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in injectable drug delivery partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about injectable drug delivery partnering in the research, development and commercialization of drug delivery technologies and products.

Report scope
Injectable Drug Delivery Partnering 2010-2015 is intended to provide the reader with an in-depth understanding and access to injectable drug delivery trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:
- Trends in injectable drug delivery dealmaking in the biopharma industry since 2010
- Access to summary headline, upfront, milestone and royalty data
- Access to over 150 injectable drug delivery actual deal records
- The leading injectable deals by value since 2010

In Injectable Drug Delivery Partnering 2010-2015, the available deals are listed by:
- Headline value
- Upfront payment value
- Royalty rate value
- Company A-Z
- Industry sector
- Stage of development at signing
- Deal component type
- Therapy type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Benefits

Injectable Drug Delivery Partnering 2010-2015 provides the reader with the following key benefits:

- In-depth understanding of injectable drug delivery deal trends since 2010
- Access to summary headline, upfront, milestone and royalty data
- Comprehensive access to over 150 actual deal records entered into by the world's biopharma companies since 2010
- Insight into key deal terms included in contracts, where disclosed
- Understand the key deal terms companies have agreed in deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Spanning over 150 pages "Global Injectable Drug Delivery Partnering 2010-2015" report covers Executive Summary, Introduction, Trends in injectable drug delivery dealmaking, Average financial deal terms for injectable drug delivery partnering, Leading injectable drug delivery deals, Injectable drug delivery partnering dealmaking directory.

For further information on this report, please visit-
http://www.marketresearchreports.com/current-partnering/global-injectable-drug-delivery-partnering-2010-2015

Related Reports:

1st- Global Targeted Drug Delivery Partnering 2010-2015 - visit at:
http://www.marketresearchreports.com/current-partnering/global-targeted-drug-delivery-partnering-2010-2015

2nd- Global Topical Drug Delivery Partnering 2010-2015 - visit at:
http://www.marketresearchreports.com/current-partnering/global-topical-drug-delivery-partnering-2010-2015

4th- Global Transdermal Drug Delivery Partnering 2010-2015 - visit at:
http://www.marketresearchreports.com/current-partnering/global-transdermal-drug-delivery-partnering-2010-2015

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter